JCEM case reports最新文献

筛选
英文 中文
Correction to: "Acquired 11β-hydroxylase Deficiency by Inhaled Etomidate and its Analogues: A Mimic of Congenital Adrenal Hyperplasia".
JCEM case reports Pub Date : 2025-01-02 eCollection Date: 2025-01-01 DOI: 10.1210/jcemcr/luae251
{"title":"Correction to: \"Acquired 11β-hydroxylase Deficiency by Inhaled Etomidate and its Analogues: A Mimic of Congenital Adrenal Hyperplasia\".","authors":"","doi":"10.1210/jcemcr/luae251","DOIUrl":"https://doi.org/10.1210/jcemcr/luae251","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1210/jcemcr/luae207.].</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"3 1","pages":"luae251"},"PeriodicalIF":0.0,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Unilateral Adrenal Anaplastic Large Cell Lymphoma: Remission by Chemotherapy.
JCEM case reports Pub Date : 2024-12-06 eCollection Date: 2024-12-01 DOI: 10.1210/jcemcr/luae229
Daisuke Goto, Yumie Takeshita, Kosuke Nagai, Hisanori Goto, Yujiro Nakano, Toshinari Takamura
{"title":"Primary Unilateral Adrenal Anaplastic Large Cell Lymphoma: Remission by Chemotherapy.","authors":"Daisuke Goto, Yumie Takeshita, Kosuke Nagai, Hisanori Goto, Yujiro Nakano, Toshinari Takamura","doi":"10.1210/jcemcr/luae229","DOIUrl":"10.1210/jcemcr/luae229","url":null,"abstract":"<p><p>Primary malignant lymphomas originating in the adrenal gland, particularly of T-cell origin, are extremely rare. Here we present the primary unilateral adrenal anaplastic large cell lymphoma case. A 64-year-old Japanese male initially presented with fatigue and appetite loss. Computed tomography imaging revealed a unilateral adrenal mass with multiorgan invasion, posing challenges in differentiation from adrenal carcinoma. A biopsy from the metastatic site in the right lateral vastus muscle was obtained, and immunohistochemistry revealed that tumor cells were positive for CD30 and CD56 and negative for CD3, CD15, CD20, CD43, perforin, granzyme B, epithelial membrane antigen, and anaplastic lymphoma kinase. Ultimately, the patient was diagnosed with primary unilateral adrenal anaplastic large cell lymphoma. Although he achieved complete response to chemotherapy, he died 4 months after complete response due to cholecystitis and lymphoma recurrence.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 12","pages":"luae229"},"PeriodicalIF":0.0,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630779/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduction of Ovarian Cysts After Endoscopic Surgery for Follicle-Stimulating Hormone-Producing Pituitary Adenoma.
JCEM case reports Pub Date : 2024-12-06 eCollection Date: 2024-12-01 DOI: 10.1210/jcemcr/luae231
Reo Ishii, Nozomi Harai, Tadatsugu Hosokawa, Ippei Tahara, Masakazu Ogiwara, Kyoichiro Tsuchiya
{"title":"Reduction of Ovarian Cysts After Endoscopic Surgery for Follicle-Stimulating Hormone-Producing Pituitary Adenoma.","authors":"Reo Ishii, Nozomi Harai, Tadatsugu Hosokawa, Ippei Tahara, Masakazu Ogiwara, Kyoichiro Tsuchiya","doi":"10.1210/jcemcr/luae231","DOIUrl":"10.1210/jcemcr/luae231","url":null,"abstract":"<p><p>A 49-year-old woman presented with irregular menstrual bleeding, elevated estradiol (E2) (665 pg/mL [2441.21 pmol/L]) (reference range [RR]: menstrual period [MP] 20-50 pg/mL; 73.42-183.55 pmol/L), unsuppressed follicle-stimulating hormone (FSH) (19.3 mIU/mL [19.3 IU/L]) (RR: MP 3.5-10.0 mIU/mL; 3.5-10.0 IU/L), and cystic ovarian enlargement (right ovary, 109 mL; left ovary, 146 mL). A 7-mm pituitary microadenoma was also observed, and 6 months after referral, endoscopic transsphenoidal surgery was performed, resulting in a diagnosis of FSH-producing pituitary adenoma. Nine months postoperatively, the ovarian cysts had markedly shrunk. Although FSH-producing pituitary adenomas are rare, approximately 64% of nonfunctioning pituitary adenomas are positive for gonadotropin immunostaining. FSH-producing pituitary adenomas are often endocrinologically silent, with symptoms typically triggered by pituitary tumor enlargement. Early diagnosis can be facilitated by measuring FSH and E2 levels in cases of irregular vaginal bleeding, abnormal menstruation, ovarian enlargement, ovarian hyperstimulation syndrome, or infertility. If E2 is elevated but FSH is not suppressed, pituitary magnetic resonance imaging should be performed to identify FSH-producing pituitary adenomas. In cases of FSH-producing pituitary adenomas, including microadenomas, symptoms may improve after tumor resection, making surgery the preferred treatment option.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 12","pages":"luae231"},"PeriodicalIF":0.0,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statin-Induced Necrotizing Autoimmune Myopathy: Diagnosis and Treatment Approach.
JCEM case reports Pub Date : 2024-12-06 eCollection Date: 2024-12-01 DOI: 10.1210/jcemcr/luae227
Varshini Srinivasan, Samyuktha Prabu, Jad G Sfeir, Kalpana Muthusamy
{"title":"Statin-Induced Necrotizing Autoimmune Myopathy: Diagnosis and Treatment Approach.","authors":"Varshini Srinivasan, Samyuktha Prabu, Jad G Sfeir, Kalpana Muthusamy","doi":"10.1210/jcemcr/luae227","DOIUrl":"10.1210/jcemcr/luae227","url":null,"abstract":"<p><p>The widespread use of statins for cardiovascular diseases has unveiled a new subset of inflammatory myopathy, immune-mediated necrotizing myopathy (IMNM). We describe below an unusual case of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) myopathy. A 64-year-old male individual with type 2 diabetes, hyperlipidemia, and coronary artery disease presented with progressive proximal muscle weakness and pain for 3 months. He took atorvastatin 40 mg for 4 years, which was discontinued due to elevated liver enzymes and resumed treatment with rosuvastatin 5 mg later due to worsening hyperlipidemia. Physical examination showed significant weakness of the hip, shoulder girdle, and biceps/triceps. Creatinine kinase (CK) was found to be 232.48 µkat/L (13 921 IU/L) (normal: 0.833-5.133 µkat/L; 50-308 IU/L). Electromyography and left vastus lateralis muscle biopsy showed findings of myonecrosis. Anti-HMGCR assay was strongly positive with antibodies > 200 chemiluminescent units (CU) (normal: 0-20 CU). He was started on prednisone followed by human-immunoglobulin (IVIG) which led to a decline in CK. Statin-induced necrotizing autoimmune myopathy (SINAM) is an exceptionally rare side effect of statins. Although statins come with a good side-effect profile, one should be aware of marked, persistent elevations in muscle enzyme levels. Prompt confirmation with antibody levels, drug discontinuation, and early initiation of immunosuppression can lead to good outcomes.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 12","pages":"luae227"},"PeriodicalIF":0.0,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperinsulinemic Hypoglycemia in a Patient With a Mutation in the Insulin Receptor.
JCEM case reports Pub Date : 2024-12-05 eCollection Date: 2024-12-01 DOI: 10.1210/jcemcr/luae221
Marcus Imamovic, Mattias Vågberg, Kristina Cederquist, Per Dahlqvist
{"title":"Hyperinsulinemic Hypoglycemia in a Patient With a Mutation in the Insulin Receptor.","authors":"Marcus Imamovic, Mattias Vågberg, Kristina Cederquist, Per Dahlqvist","doi":"10.1210/jcemcr/luae221","DOIUrl":"10.1210/jcemcr/luae221","url":null,"abstract":"<p><p>Hyperinsulinemic hypoglycemias resulting from variants in the insulin receptor (<i>INSR</i>) gene are rare but clinically important disorders. We present a male patient in his 30s, experiencing recurrent postprandial hypoglycemic events. Endocrine evaluation revealed an elevated insulin-to-C-peptide ratio. A hypoglycemia gene panel, using next-generation sequencing, identified a heterozygous nonsense variant in the <i>INSR</i> gene (NM_000208.4) c.3079C > T, p.(Arg1027*). Initial treatment with diazoxide reduced hypoglycemic symptoms and led to weight loss and decreased hemoglobin A1c due to reduced compensatory carbohydrate intake. However, limiting side effects on diazoxide prompted a treatment switch to lanreotide with maintained absence of hypoglycemic events. This case highlights the importance of considering variants in the <i>INSR</i> gene as a differential diagnosis in hyperinsulinemic hypoglycemia cases, even in adults.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 12","pages":"luae221"},"PeriodicalIF":0.0,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Localization of Recurrent MEN-1-Associated Hyperparathyroidism With 18F-Fluorocholine PET/CT.
JCEM case reports Pub Date : 2024-12-04 eCollection Date: 2024-12-01 DOI: 10.1210/jcemcr/luae222
Elizabeth Wootton, Clement Wong, Amanda Love, David A Pattison
{"title":"Successful Localization of Recurrent MEN-1-Associated Hyperparathyroidism With 18F-Fluorocholine PET/CT.","authors":"Elizabeth Wootton, Clement Wong, Amanda Love, David A Pattison","doi":"10.1210/jcemcr/luae222","DOIUrl":"10.1210/jcemcr/luae222","url":null,"abstract":"","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 12","pages":"luae222"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Presentation and Management of Highly Differentiated Follicular Carcinoma of Ovarian Origin With DICER1 Gene Variants.
JCEM case reports Pub Date : 2024-12-04 eCollection Date: 2024-12-01 DOI: 10.1210/jcemcr/luae223
Susan Seav, Mazen Atiq, Ying-Chun Lo, Jagruti Shah, Oliver Dorigo, Chrysoula Dosiou
{"title":"Presentation and Management of Highly Differentiated Follicular Carcinoma of Ovarian Origin With <i>DICER1</i> Gene Variants.","authors":"Susan Seav, Mazen Atiq, Ying-Chun Lo, Jagruti Shah, Oliver Dorigo, Chrysoula Dosiou","doi":"10.1210/jcemcr/luae223","DOIUrl":"10.1210/jcemcr/luae223","url":null,"abstract":"<p><p>Struma ovarii (SO) is a rare subtype of ovarian teratoma composed of more than 50% thyroid tissue. Extraovarian spread of SO, called peritoneal strumosis, was previously considered benign given the lack of histological malignant features. However, the 2020 World Health Organization Classification of Female Genital Tumors reclassified peritoneal strumosis as highly differentiated follicular carcinoma of ovarian origin (HDFCO), highlighting its low-grade malignant potential. We present a 38-year-old woman with SO treated initially with right salpingo-oophorectomy, with recurrence 2 years later with multifocal metastatic lesions in the abdomen and pelvis that was successfully treated with surgical resection, total thyroidectomy, and 157 mCi of I-131. Tumor molecular testing revealed a pathogenic <i>DICER1</i> variant (c.5428G>T, exon 25). A second variant (c.319delins13, exon 4) was of uncertain significance. Germline testing confirmed the second <i>DICER1</i> variant and also identified an increased risk variant in the <i>APC</i> gene (c.3920T>A). This is a rare case of extensive HFDCO with <i>DICER1</i> variants, which has been associated with thyroid cancer. Given the germline <i>DICER1</i> variant, this may also represent the first reported instance of DICER1 syndrome manifesting as HDFCO. Further research into the prognostic factors and optimal treatment of HFDCO is needed.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 12","pages":"luae223"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mild Congenital Hyperinsulinism Caused by Mutation in Human Glucokinase Gene.
JCEM case reports Pub Date : 2024-12-04 eCollection Date: 2024-12-01 DOI: 10.1210/jcemcr/luae226
Leila Salikhovna Sozaeva, Sabina Kalandarovna Ismailova, Irina Yurievna Chernyak, Sergey Vladimirovich Popov, Victoriya Vitalievna Zakharova, Igor Sergeevich Chugunov
{"title":"Mild Congenital Hyperinsulinism Caused by Mutation in Human <i>Glucokinase</i> Gene.","authors":"Leila Salikhovna Sozaeva, Sabina Kalandarovna Ismailova, Irina Yurievna Chernyak, Sergey Vladimirovich Popov, Victoriya Vitalievna Zakharova, Igor Sergeevich Chugunov","doi":"10.1210/jcemcr/luae226","DOIUrl":"10.1210/jcemcr/luae226","url":null,"abstract":"<p><p>Congenital hyperinsulinism (CHI) is a rare hereditary disease characterized by the development of hypoglycemia in both infants and adult patients. CHI may be induced by activating mutations in the <i>glucokinase</i> (<i>GCK</i>) gene, which encodes the human glucokinase enzyme. This form of the disease is characterized by considerable phenotypic heterogeneity and may vary in severity of its course. We present a familial case report of mild CHI caused by a novel variant, c.212T > C (p.Val71Ala), in the <i>GCK</i> gene in a 41-year-old mother and a 15-year-old daughter. The clinical picture of hypoglycemia in the patients was not pronounced, which makes this clinical case remarkable. Moreover, a variant of uncertain clinical significance, с.1903G > A (p.Ala635Thr), in the <i>ABCC8</i> gene was detected, which may also have contributed to the course of the disease in these patients.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 12","pages":"luae226"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diazoxide-Responsive Hypoglycemia in a Child Receiving Dasatinib for Treatment of B-Cell Acute Lymphoblastic Leukemia.
JCEM case reports Pub Date : 2024-12-04 eCollection Date: 2024-12-01 DOI: 10.1210/jcemcr/luae219
Madalin Berra, Juliana Biro, Himala Kashmiri, Mark Daniels
{"title":"Diazoxide-Responsive Hypoglycemia in a Child Receiving Dasatinib for Treatment of B-Cell Acute Lymphoblastic Leukemia.","authors":"Madalin Berra, Juliana Biro, Himala Kashmiri, Mark Daniels","doi":"10.1210/jcemcr/luae219","DOIUrl":"10.1210/jcemcr/luae219","url":null,"abstract":"<p><p>Tyrosine kinase inhibitors (TKIs) are being used more regularly in treatment regimens for pediatric cancers. They have distinct side effect profiles, including endocrinopathies. Here we present a 2-year-old boy with Philadelphia chromosome-like (Ph-like) B-cell acute lymphoblastic leukemia (ALL) who developed refractory hypoglycemia after using dasatinib. His evaluation was suggestive of hyperinsulinism, and his symptoms were ultimately controlled with diazoxide. There have not been any published data exploring the relationship between TKIs and glycemic profiles in pediatric patients. In adults, there is research indicating that patients using TKIs could experience both hyperglycemia and hypoglycemia. The pathophysiology of these side effects is not well described, nor are the risk factors for development. More research is needed to understand these relationships in general, but particularly in the pediatric population.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 12","pages":"luae219"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11629982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pachydermoperiostosis Due to a Novel HPGD Splicing Site Mutation Masquerading as Acromegaly.
JCEM case reports Pub Date : 2024-12-03 eCollection Date: 2024-12-01 DOI: 10.1210/jcemcr/luae215
Mussa Almalki, Balgees Alghamdi, Allianah Benito, Ahmed Alfares, Ali S Alzahrani
{"title":"Pachydermoperiostosis Due to a Novel <i>HPGD</i> Splicing Site Mutation Masquerading as Acromegaly.","authors":"Mussa Almalki, Balgees Alghamdi, Allianah Benito, Ahmed Alfares, Ali S Alzahrani","doi":"10.1210/jcemcr/luae215","DOIUrl":"10.1210/jcemcr/luae215","url":null,"abstract":"<p><p>Hypertrophic osteoarthropathy (HOA: MIM 167100)) is classified into primary and secondary types. Primary HOA, also known as pachydermoperiostosis (PDP), is a rare genetic condition with distinct clinical features including digital clubbing, skin thickening, and periostosis. Secondary HOA often occurs as a paraneoplastic syndrome or is associated with systemic diseases. In this report, we present a 17-year-old male patient who initially presented with significant digital clubbing, enlarged hands and feet, and excessive sweating. Although the initial suspected diagnosis was acromegaly, the patient's plasma level of insulin-like growth factor 1 was normal and growth hormone levels suppressed to <1 ng/dL following oral glucose tolerance test. Whole exome sequencing followed by Sanger sequencing of leukocyte deoxyribonucleic acid revealed a novel splicing variant in the 15-hydroxyprostaglandin dehydrogenase (<i>HPGD</i>) gene (NM_000860.6: c.662 + 5_662 + 8del). Reverse transcription polymerase chain reaction confirmed that this variant led to defective splicing with skipping of exon 6, a frameshift, and truncation at codon 13 of exon 7 downstream. His symptoms did not respond well to nonsteroidal anti-inflammatory drugs but showed excellent response to a trial of lanreotide autogel that has been used for about 1 year.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"2 12","pages":"luae215"},"PeriodicalIF":0.0,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信